These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28510291)

  • 1. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
    Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
    Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans.
    Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA
    Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-ethnic transcriptome-wide association study of prostate cancer.
    Fiorica PN; Schubert R; Morris JD; Abdul Sami M; Wheeler HE
    PLoS One; 2020; 15(9):e0236209. PubMed ID: 32986714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.
    Haiman CA; Han Y; Feng Y; Xia L; Hsu C; Sheng X; Pooler LC; Patel Y; Kolonel LN; Carter E; Park K; Le Marchand L; Van Den Berg D; Henderson BE; Stram DO
    PLoS Genet; 2013 Mar; 9(3):e1003419. PubMed ID: 23555315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.
    Freedman JA; Wang Y; Li X; Liu H; Moorman PG; George DJ; Lee NH; Hyslop T; Wei Q; Patierno SR
    Carcinogenesis; 2018 Jul; 39(7):879-888. PubMed ID: 29726910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GWAS SNP Replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP).
    Xu Z; Bensen JT; Smith GJ; Mohler JL; Taylor JA
    Prostate; 2011 Jun; 71(8):881-91. PubMed ID: 21456070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide pleiotropy scan for prostate cancer risk.
    Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
    Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
    Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
    J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.
    Vidal AC; Tucker C; Schildkraut JM; Richardson RM; McPhail M; Freedland SJ; Hoyo C; Grant DJ
    BMC Cancer; 2013 Nov; 13():556. PubMed ID: 24267955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of
    Lin HY; Callan CY; Fang Z; Tung HY; Park JY
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans.
    Sun J; Purcell L; Gao Z; Isaacs SD; Wiley KE; Hsu FC; Liu W; Duggan D; Carpten JD; Grönberg H; Xu J; Chang BL; Partin AW; Walsh PC; Isaacs WB; Zheng SL
    Prostate; 2008 May; 68(7):691-7. PubMed ID: 18361410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer risk associated loci in African Americans.
    Xu J; Kibel AS; Hu JJ; Turner AR; Pruett K; Zheng SL; Sun J; Isaacs SD; Wiley KE; Kim ST; Hsu FC; Wu W; Torti FM; Walsh PC; Chang BL; Isaacs WB
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2145-9. PubMed ID: 19549807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication and heritability of prostate cancer risk variants: impact of population-specific factors.
    Virlogeux V; Graff RE; Hoffmann TJ; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):938-43. PubMed ID: 25809866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-mapping IGF1 and prostate cancer risk in African Americans: the multiethnic cohort study.
    Giorgi EE; Stram DO; Taverna D; Turner SD; Schumacher F; Haiman CA; Lum-Jones A; Tirikainen M; Caberto C; Duggan D; Henderson BE; Le Marchand L; Cheng I
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1928-32. PubMed ID: 24904019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions.
    Han Y; Hazelett DJ; Wiklund F; Schumacher FR; Stram DO; Berndt SI; Wang Z; Rand KA; Hoover RN; Machiela MJ; Yeager M; Burdette L; Chung CC; Hutchinson A; Yu K; Xu J; Travis RC; Key TJ; Siddiq A; Canzian F; Takahashi A; Kubo M; Stanford JL; Kolb S; Gapstur SM; Diver WR; Stevens VL; Strom SS; Pettaway CA; Al Olama AA; Kote-Jarai Z; Eeles RA; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Chokkalingam AP; Isaacs WB; Chen C; Lindstrom S; Le Marchand L; Giovannucci EL; Pomerantz M; Long H; Li F; Ma J; Stampfer M; John EM; Ingles SA; Kittles RA; Murphy AB; Blot WJ; Signorello LB; Zheng W; Albanes D; Virtamo J; Weinstein S; Nemesure B; Carpten J; Leske MC; Wu SY; Hennis AJ; Rybicki BA; Neslund-Dudas C; Hsing AW; Chu L; Goodman PJ; Klein EA; Zheng SL; Witte JS; Casey G; Riboli E; Li Q; Freedman ML; Hunter DJ; Gronberg H; Cook MB; Nakagawa H; Kraft P; Chanock SJ; Easton DF; Henderson BE; Coetzee GA; Conti DV; Haiman CA
    Hum Mol Genet; 2015 Oct; 24(19):5603-18. PubMed ID: 26162851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.
    Agalliu I; Kwon EM; Salinas CA; Koopmeiners JS; Ostrander EA; Stanford JL
    Cancer Causes Control; 2010 Feb; 21(2):289-300. PubMed ID: 19902366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-mapping of IL16 gene and prostate cancer risk in African Americans.
    Batai K; Shah E; Murphy AB; Newsome J; Ruden M; Ahaghotu C; Kittles RA
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2059-68. PubMed ID: 22923025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population.
    Gaj P; Maryan N; Hennig EE; Ledwon JK; Paziewska A; Majewska A; Karczmarski J; Nesteruk M; Wolski J; Antoniewicz AA; Przytulski K; Rutkowski A; Teumer A; Homuth G; Starzyńska T; Regula J; Ostrowski J
    PLoS One; 2012; 7(4):e35307. PubMed ID: 22532847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.